Documents & Downloads

DHX9-IN-13

DHX9 Inhibitor

DHX9-IN-13 is a selective inhibitor of the RNA helicase DHX9, exhibiting an EC50 of 3.4 μM in cellular assays. This compound is primarily utilized in cancer research to elucidate the role of DHX9 in tumorigenesis and associated signaling pathways. Its mechanism of action allows for the investigation of RNA metabolism and the potential therapeutic targeting of DHX9 in cancer treatment strategies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2973399-28-7
Applications	DHX9 Inhibitor
Formula	C₁₈H₁₆Cl₂N₄O₃S
Molecular Weight	439.32
SMILES	O=C(C1=CN(C2=NC=C(C=C2)Cl)C(C)=C1)NC3=CC(Cl)=CC(NS(=O)(C)=O)=C3

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.